ImpediMed Limited Stock
Stocks
IPD
AU000000IPD8
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Australian S.E.
21:13:16 2026-09-03 EDT
|
5-day change | 1st Jan Change | ||
| 0.005500 AUD | +10.00% |
|
+10.00% | -83.82% |
| 08-27 | ImpediMed Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
| 08-26 | ImpediMed Limited Auditor Raises 'Going Concern' Doubt | CI |
| Market Cap | 20.14M 14.52M 12.49M 11.76M 10.74M 20.09M 1.37B 139M 53.9M 703M 54.52M 53.34M 2.27B | P/E 2027 * |
-1.65x | P/E 2028 * | -3.64x |
|---|---|---|---|---|---|
| Enterprise Value | 29.44M 21.22M 18.26M 17.18M 15.7M 29.36M 2B 203M 78.79M 1.03B 79.7M 77.96M 3.31B | EV / Sales 2027 * |
1.5x | EV / Sales 2028 * | 1x |
| Free-Float |
92.02% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| IPD | Delayed | |
OTC Markets
| IPDQF | Delayed | |
|
Deutsche Boerse AG
| R1J | Delayed |
Last Transcript : ImpediMed Limited
| 01-30 | Bell Potter rates IPD as Speculative Buy | AQ |
| 01-30 | Morgans rates IPD as Speculative Buy | AQ |
| 25-02-10 | ImpediMed Secures $15m Growth Capital Funding | AQ |
| 24-07-04 | Morgans rates IPD as Add | AQ |
| 24-04-30 | Ord Minnett rates IPD as Speculaitve Buy | AQ |
| 1 day | +10.00% | ||
| 1 week | +10.00% | ||
| Current month | +10.00% | ||
| 1 month | +10.00% | ||
| 3 months | -21.43% | ||
| 6 months | -67.65% | ||
| Current year | -83.82% |
| 1 week | 0 |  | 0.01 |
| 1 month | 0 | | 0.01 |
| Current year | 0 | | 0.04 |
| 1 year | 0 | | 0.06 |
| 3 years | 0 | | 0.2 |
| 5 years | 0 | | 0.24 |
| 10 years | 0 | | 1.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
Erik Anderson
CEO | Chief Executive Officer | - | 2026-04-06 |
McGregor Grant
DFI | Director of Finance/CFO | - | 2023-11-19 |
Steven Chen
CTO | Chief Tech/Sci/R&D Officer | - | 2023-09-25 |
| Director | Title | Age | Since |
|---|---|---|---|
McGregor Grant
CHM | Chairman | - | - |
| Chairman | - | 2024-02-25 | |
Janelle Delaney
BRD | Director/Board Member | - | 2023-09-27 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/16/26 | Buy | Chairman | 146,408 | 0.0072% | ||
| 1/16/26 | Buy | Director | 100,563 | 0.0049% | ||
| 1/16/26 | Buy | Director | 100,563 | 0.0049% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +10.00% | +10.00% | -85.90% | -96.86% | 14.52M | |
| -0.75% | -1.35% | +24.60% | +13.24% | 227B | |
| -1.60% | -3.89% | +3.72% | -20.39% | 146B | |
| -0.85% | -1.58% | -21.45% | +19.18% | 130B | |
| +1.81% | +2.05% | -55.42% | -10.32% | 69.27B | |
| +0.13% | -0.34% | +11.07% | +18.34% | 51.82B | |
| +0.49% | -1.32% | -17.44% | -13.87% | 50.45B | |
| +0.59% | -1.94% | +17.17% | +27.06% | 42.53B | |
| -1.01% | -1.28% | +33.64% | +48.14% | 40.22B | |
| -1.55% | +1.22% | +120.58% | +36.88% | 32.95B | |
| Average | +0.73% | -0.41% | +3.06% | +2.14% | 78.97B | |
| Weighted average by Cap. | -0.54% | -1.55% | +6.66% | +8.04% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 19.64M 14.15M 12.18M 11.46M 10.47M 19.58M 1.34B 135M 52.55M 686M 53.15M 51.99M 2.21B | 27.58M 19.88M 17.11M 16.1M 14.7M 27.51M 1.88B 190M 73.8M 963M 74.65M 73.02M 3.1B |
| Net income | -15.25M -10.99M -9.46M -8.9M -8.13M -15.21M -1.04B -105M -40.81M -533M -41.28M -40.38M -1.72B | -6.26M -4.51M -3.88M -3.65M -3.34M -6.25M -426M -43.19M -16.76M -219M -16.95M -16.58M -704M |
| Net Debt | 9.3M 6.7M 5.77M 5.43M 4.96M 9.27M 633M 64.13M 24.89M 325M 25.17M 24.62M 1.05B | 7.39M 5.33M 4.59M 4.31M 3.94M 7.37M 503M 50.98M 19.78M 258M 20.01M 19.57M 832M |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-04 | A$0.005500 | +10.00% | 1,290,265 |
| 26-09-03 | A$0.005000 | 0.00% | 25,421 |
| 26-09-02 | A$0.005000 | -9.09% | 80,276 |
| 26-09-01 | A$0.005500 | +10.00% | 291,666 |
| 26-08-31 | A$0.005000 | 0.00% | 1,305,827 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IPD Stock
Select your edition
All financial news and data tailored to specific country editions
